Suppression of dendritic cell differentiation through cytokines released by Primary Effusion Lymphoma cells

Immunology Letters

Volumn 120, Issue 1-2, 2008, Pages 37-41

  Cirone, Mara ^a   Lucania, Giuseppe ^a   Aleandri, Silvia ^a   Borgia, Giuliana ^a   Trivedi, Pankaj ^a   Cuomo, Laura ^b   Frati, Luigi ^a   Faggioni, Alberto ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ACO S Filippo Neri   (Italy)

Author keywords

Dendritic cells; PEL; Tumor culture supernatants

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD34 ANTIGEN; CD86 ANTIGEN; CYTOKINE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; T6 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ARTICLE; CANCER PATIENT; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; LYMPHOMA CELL; MONOCYTE; PHENOTYPE; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; SOLID TUMOR; SUPERNATANT; TUMOR GROWTH; TUMOR IMMUNITY;

CELL DIFFERENTIATION; CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LYMPHOMA, PRIMARY EFFUSION; PHENOTYPE;

EID: 50849145149     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.06.011     Document Type: Article

References (22)

1. Banchereau J., Breire F., Caux C., Davoust J., Lebecque S., Liu Y.J., et al. Immunobiology of dendritic cells. Annu Rev Immunol 18 (2000) 767-811
2. Lanzavecchia A., and Sallusto F. Regulation of T cell immunity by dendritic cells. Cell 106 (2001) 263-266
3. Lutz B.M., and Schuler G. Immature, semimature and fully mature dendritic cells: which signals induce tolerance or immunity?. Trends Immunol 23 (2002) 445-449
4. Orsini E., Guarini A., Chiaretti S., Mauro F.R., and Foa R. The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is defective and unable to stimulate an effective T-cell response. Cancer Res 63 (2003) 4497-4506
5. Enk A.H., Jonuleit H., Saloga J., and Knop J. Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int J Cancer 73 (1997) 309-316
6. Stebbing J., Gazzard B., Portsmouth S., Gotch F., Kim L., Bower M., et al. Disease-associated dendritic cells respond to disease-specific antigens through the common heat shock protein receptor. Blood 102 (2003) 1806-1814
7. Della Bella S., Nicola S., Brambilla L., Riva A., Ferrucci S., Presicce P., et al. Quantitative and functional defects of dendritic cells in classic Kaposi's sarcoma. Clin Immunol 119 (2006) 317-329
8. Nador R.G., Cesarman E., Chadburn A., Dawson D.B., Ansari M.Q., Sald J., et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 88 2 (1996) 645-656
9. Ensoli B., Stürzl M., and Monini P. Cytokine-mediated growth promotion of Kaposi's sarcoma and primary effusion lymphoma. Sem Cancer Biol 10 (2000) 367-381
10. Cirone M., Lucania G., Bergamo P., Trivedi P., Frati L., and Faggioni A. Human herpesvirus 8 (HHV-8) inhibits monocyte differentiation into dendritic cells and impairs their immunostimulatory activity. Immunol Lett 113 (2007) 40-46
11. Coventry B., and Heinzel S. CD1a in human cancers: a new role for an old molecule. Trends Immunol 25 (2004) 242-248
12. Yanagimoto H., Takai S., Satoi S., Toyokawa H., Takahashi K., Terakawa N., et al. Impaired function of circulating dendritic cells in patients with pancreatic cancer. Clin Immunol 114 (2005) 52-60
13. Gabrilovich D.I., Chen H.L., Girgis K.R., Cunningham H.T., Meny G.M., Nadaf S., et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2 (1996) 1096-1103
14. Li L., Li S.P., Min J., and Zheng L. Hepatoma cells inhibit the differentiation and maturation of dendritic cells and increase the production of regulatory T cells. Immunol Lett 114 (2007) 38-45
15. Jones K.D., Aoki Y., Chang Y., Moore P.S., Yarchoan R., and Tosato G. Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells. Blood 94 (1999) 2871-2879
16. Aoki Y., and Tosato G. Role of vascular endothelial growth factor/vascular permeability factor in the pathogenesis of Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphomas. Blood 94 (1999) 4247-4254
17. Buelens C., Verhasselt V., De Groote D., Thielemans K., Goldman M., and Willems F. Interleukin-10 èrevents the generation of dendritic cells from human perphel blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor. Eur J Immunol 27 (1997) 756-762
18. Allavena P., Piemonti L., Longoni D., Bernasconi S., Stoppacciaro A., Ruco L., et al. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur J Immunol 28 (1998 Jan) 359-369
19. Johnson B.F., Clay T.M., Hobeika A.C., Lyerly H.K., and Morse M.A. Vascular endothelial growth factor and immunosuppression in cancer: current knowledge and potential for new therapy. Expert Opin Biol Ther 7 (2007) 449-460
20. Chomarat P., Banchereau J., Davoust J., and Palucka A.K. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol 1 (2000) 510-514
21. Bharadwaj U., Li M., Zhang R., Chen C., and Yao Q. Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation. Cancer Res 67 (2007) 5479-5488
22. Gottfried E., Kreutz M., and Mackensen A. Tumor-induced modulation of dendritic cell function. Cytokine Growth Factor Rev 19 (2007) 65-77